• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6和肿瘤坏死因子-α与肺动脉高压中与生活质量相关的症状有关。

Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.

作者信息

Matura Lea Ann, Ventetuolo Corey E, Palevsky Harold I, Lederer David J, Horn Evelyn M, Mathai Stephen C, Pinder Diane, Archer-Chicko Christine, Bagiella Emilia, Roberts Kari E, Tracy Russell P, Hassoun Paul M, Girgis Reda E, Kawut Steven M

机构信息

1 University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.

出版信息

Ann Am Thorac Soc. 2015 Mar;12(3):370-5. doi: 10.1513/AnnalsATS.201410-463OC.

DOI:10.1513/AnnalsATS.201410-463OC
PMID:25615959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4418312/
Abstract

RATIONALE

Inflammation is associated with symptoms in many chronic illnesses; however, this link has not been established in pulmonary arterial hypertension.

OBJECTIVES

The objective of this study was to investigate the association between inflammatory markers and quality of life-related symptoms in patients with pulmonary arterial hypertension. We hypothesized that higher circulating IL-6 and tumor necrosis factor-α levels would be associated with worse quality of life-related symptoms.

METHODS

We performed a secondary analysis using baseline and 3-month assessments of 62 subjects in a clinical trial of aspirin and simvastatin to determine the association between plasma IL-6 and tumor necrosis factor-α levels and the Medical Outcomes Study Short Form-36 subscales (pain, vitality, mental health).

MEASUREMENTS AND MAIN RESULTS

The mean age was 49.7±13.4 years; 87% were female. Higher IL-6 levels were significantly associated with lower Medical Outcomes Study Short Form-36 subscale scores, indicating worse bodily pain, vitality, and mental health (all P<0.01). Higher tumor necrosis factor-α levels were significantly associated with increased bodily pain, but better mental health scores.

CONCLUSIONS

IL-6 and tumor necrosis factor-α levels are associated with certain quality of life domains in patients with pulmonary arterial hypertension. Clinical trial registered with www.clinicaltrials.gov (NCT00384865).

摘要

原理

炎症与许多慢性疾病的症状相关;然而,这种联系在肺动脉高压中尚未得到证实。

目的

本研究的目的是调查肺动脉高压患者炎症标志物与生活质量相关症状之间的关联。我们假设循环中白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平升高与生活质量相关症状恶化有关。

方法

我们在一项阿司匹林和辛伐他汀的临床试验中,对62名受试者的基线和3个月评估进行了二次分析,以确定血浆IL-6和TNF-α水平与医学结局研究简明健康调查36项量表(疼痛、活力、心理健康)之间的关联。

测量指标与主要结果

平均年龄为49.7±13.4岁;87%为女性。较高的IL-6水平与较低的医学结局研究简明健康调查36项量表评分显著相关,表明身体疼痛、活力和心理健康状况较差(所有P<0.01)。较高的TNF-α水平与身体疼痛增加显著相关,但心理健康评分较好。

结论

IL-6和TNF-α水平与肺动脉高压患者的某些生活质量领域相关。临床试验已在www.clinicaltrials.gov注册(NCT00384865)。

相似文献

1
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.白细胞介素-6和肿瘤坏死因子-α与肺动脉高压中与生活质量相关的症状有关。
Ann Am Thorac Soc. 2015 Mar;12(3):370-5. doi: 10.1513/AnnalsATS.201410-463OC.
2
Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT.阿司匹林和辛伐他汀治疗肺动脉高压的 II 期临床试验的原理和设计:ASA-STAT。
Contemp Clin Trials. 2011 Mar;32(2):280-7. doi: 10.1016/j.cct.2010.12.005. Epub 2010 Dec 10.
3
Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.生物标志物在肺动脉高压中的预后意义
Ann Am Thorac Soc. 2016 Jan;13(1):25-30. doi: 10.1513/AnnalsATS.201508-543OC.
4
Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.铁蛋白水平、炎症生物标志物与外周动脉疾病患者的死亡率:铁(Fe)与动脉粥样硬化研究(FeAST)试验的子研究。
J Vasc Surg. 2010 Jun;51(6):1498-503. doi: 10.1016/j.jvs.2009.12.068. Epub 2010 Mar 20.
5
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者血浆单核细胞趋化蛋白-1水平升高。
Respirology. 2006 Mar;11(2):158-63. doi: 10.1111/j.1440-1843.2006.00821.x.
6
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination.冠状动脉手术期间的炎症激活及其由他汀类药物/血管紧张素转换酶抑制剂联合用药的剂量依赖性调节
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2750-5. doi: 10.1161/ATVBAHA.107.149039. Epub 2007 Sep 6.
7
Systemic inflammation in patients with COPD and pulmonary hypertension.慢性阻塞性肺疾病(COPD)合并肺动脉高压患者的全身炎症
Chest. 2006 Aug;130(2):326-33. doi: 10.1378/chest.130.2.326.
8
The evening versus morning polypill utilization study: the TEMPUS rationale and design.晚间与晨间复方制剂使用研究:TEMPUS的基本原理与设计
Eur J Prev Cardiol. 2014 Apr;21(4):425-33. doi: 10.1177/2047487313476961. Epub 2013 Feb 4.
9
Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.他达拉非和辛伐他汀对野百合碱诱导的肺动脉高压大鼠的协同作用。
Scand Cardiovasc J. 2012 Dec;46(6):374-80. doi: 10.3109/14017431.2012.729272. Epub 2012 Sep 28.
10
Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass.辛伐他汀对体外循环后全身炎症反应的影响。
J Cardiovasc Surg (Torino). 2009 Oct;50(5):687-94.

引用本文的文献

1
Plasma IL4 Levels Linked to Pulmonary Hypertension Severity and Outcome.血浆白细胞介素4水平与肺动脉高压的严重程度及预后相关。
Clin Exp Pharmacol Physiol. 2025 Jun;52(6):e70040. doi: 10.1111/1440-1681.70040.
2
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions.肺动脉高压中的循环生物标志物:最新综述与未来方向
JHLT Open. 2024 Aug 23;6:100152. doi: 10.1016/j.jhlto.2024.100152. eCollection 2024 Nov.
3
Identification and Analysis of Differentially Expressed Genes Associated with Ferroptosis and HIV in PASMCs Based on Bioinformatics.基于生物信息学的肺动脉平滑肌细胞中与铁死亡和 HIV 相关的差异表达基因的鉴定和分析。
Curr HIV Res. 2024;22(5):308-317. doi: 10.2174/011570162X304876240821062047.
4
TNFα Induces DNA and Histone Hypomethylation and Pulmonary Artery Smooth Muscle Cell Proliferation Partly via Excessive Superoxide Formation.肿瘤坏死因子α通过过量生成超氧化物部分诱导DNA和组蛋白低甲基化以及肺动脉平滑肌细胞增殖。
Antioxidants (Basel). 2024 May 31;13(6):677. doi: 10.3390/antiox13060677.
5
Microenvironmental regulation of T-cells in pulmonary hypertension.肺高血压中 T 细胞的微环境调控。
Front Immunol. 2023 Jul 11;14:1223122. doi: 10.3389/fimmu.2023.1223122. eCollection 2023.
6
Inflammation and Oxidative Stress Induce NGF Secretion by Pulmonary Arterial Cells through a TGF-β1-Dependent Mechanism.炎症和氧化应激通过 TGF-β1 依赖的机制诱导肺动脉细胞分泌 NGF。
Cells. 2022 Sep 7;11(18):2795. doi: 10.3390/cells11182795.
7
Cigarette smoke extract stimulates human pulmonary artery smooth muscle cell proliferation: Role of inflammation and oxidative stress.香烟烟雾提取物刺激人肺动脉平滑肌细胞增殖:炎症和氧化应激的作用。
Iran J Basic Med Sci. 2022 Jun;25(6):755-761. doi: 10.22038/IJBMS.2022.64170.14133.
8
Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer.肺动脉高压中失调的免疫:从伴随者到主导者。
Front Physiol. 2022 Feb 17;13:819145. doi: 10.3389/fphys.2022.819145. eCollection 2022.
9
Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial.脱氢表雄酮在肺动脉高压中的作用(EDIPHY)试验的实验设计
Pulm Circ. 2021 May 21;11(2):2045894021989554. doi: 10.1177/2045894021989554. eCollection 2021 Apr-Jun.
10
Plasma markers in pulmonary hypertension subgroups correlate with patient survival.肺高血压亚组中的血浆标志物与患者生存率相关。
Respir Res. 2021 May 4;22(1):137. doi: 10.1186/s12931-021-01716-w.

本文引用的文献

1
Effects of prostacyclin on the early inflammatory response in patients with traumatic brain injury-a randomised clinical study.前列环素对创伤性脑损伤患者早期炎症反应的影响——一项随机临床研究
Springerplus. 2014 Feb 18;3:98. doi: 10.1186/2193-1801-3-98. eCollection 2014.
2
Depressive symptoms, pain, chronic medical morbidity, and interleukin-6 among primary care patients.基层医疗患者中的抑郁症状、疼痛、慢性医疗病况和白细胞介素-6。
Pain Med. 2013 May;14(5):686-91. doi: 10.1111/pme.12089. Epub 2013 Apr 22.
3
Anxiety disorders and inflammation in a large adult cohort.焦虑障碍与炎症在一个大型成人队列中的关系。
Transl Psychiatry. 2013 Apr 23;3(4):e249. doi: 10.1038/tp.2013.27.
4
Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.在 REVEAL 注册研究中肺动脉高压患者的功能分级改善与 3 年生存结局。
Chest. 2013 Jul;144(1):160-168. doi: 10.1378/chest.12-2417.
5
Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension.社会经济地位较低与肺动脉高压的预后较差相关。
Am J Respir Crit Care Med. 2013 Feb 1;187(3):303-10. doi: 10.1164/rccm.201207-1290OC. Epub 2012 Dec 6.
6
Health-related quality of life and psychological states in patients with pulmonary arterial hypertension.肺动脉高压患者的健康相关生活质量和心理状态。
J Cardiovasc Nurs. 2014 Mar-Apr;29(2):178-84. doi: 10.1097/JCN.0b013e318275330d.
7
Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study.C 反应蛋白和白细胞介素-6 与白厅 II 前瞻性队列研究中新发疲劳的关系。
Psychol Med. 2013 Aug;43(8):1773-83. doi: 10.1017/S0033291712002437. Epub 2012 Nov 14.
8
Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer.年龄、体能状态、癌症活动度和白细胞介素-6 对转移性乳腺癌患者焦虑和抑郁的影响。
Breast Cancer Res Treat. 2012 Dec;136(3):789-94. doi: 10.1007/s10549-012-2311-2. Epub 2012 Nov 3.
9
Positive affect dimensions and their association with inflammatory biomarkers in patients with chronic heart failure.积极情绪维度及其与慢性心力衰竭患者炎症生物标志物的相关性。
Biol Psychol. 2013 Feb;92(2):220-6. doi: 10.1016/j.biopsycho.2012.10.002. Epub 2012 Oct 23.
10
Fatigue, inflammation, and projected mortality in heart failure.心力衰竭中的疲劳、炎症与预期死亡率。
J Card Fail. 2012 Sep;18(9):711-6. doi: 10.1016/j.cardfail.2012.07.003.